Atlas Trials

Pharmacokinetics of Anacetrapib (MK0859) in Subjects With Impaired Renal Function (MK-0859-038)

Clinical trial NCT01122667 · COMPLETED

Trial details

NCT number
NCT01122667
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Dyslipidemia
Start date
2010-06-01
Primary completion
2011-06-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.